Patents by Inventor FRANK SCHOENEN

FRANK SCHOENEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180282264
    Abstract: The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
    Type: Application
    Filed: November 4, 2015
    Publication date: October 4, 2018
    Inventors: Sudeshna ROY, Paolo BERNARDI, Michael FORTE, Frank SCHOENEN, Justina SILEIKYTE
  • Patent number: 9783599
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 10, 2017
    Assignee: Patrys Limited
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Andreas Thalheimer, Leodevico L. Ilag, Barbara E. Power, Lishanthi Udabage, Frank Hensel, Frank Schoenen, Arndt-Rene Kelter, Christopher Garth Hosking
  • Patent number: 9688653
    Abstract: This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: June 27, 2017
    Assignees: Duke University, University of Kansas, Southern Research Institute
    Inventors: Patrick C. Seed, Carlos C. Goller, Steven Rogers, Brooks Maki, Frank Schoenen, James Noah, E. Lucile White
  • Patent number: 9593095
    Abstract: This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: March 14, 2017
    Assignees: Duke University, University of Kansas, Southern Research Institute
    Inventors: Patrick C. Seed, Carlos C. Goller, Steven Rogers, Brooks Maki, Frank Schoenen, James Noah, E. Lucile White
  • Publication number: 20150071931
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: March 14, 2014
    Publication date: March 12, 2015
    Applicant: Patrys Limited
    Inventors: Heinz Peter Vollmers, Stephanie Ute Brandlein, Andreas Thalheimer, Leodevico L. Ilag, Barbara E. Power, Lishanthi Udabage, Frank Hensel, Frank Schoenen, Arndt-Rene Kelter, Christopher Garth Hosking
  • Publication number: 20150031658
    Abstract: This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.
    Type: Application
    Filed: October 15, 2014
    Publication date: January 29, 2015
    Inventors: Patrick C. Seed, Carlos C. Goller, Apurba Dutta, Brooks Maki, Frank Schoenen, James Noah, Lucile White
  • Publication number: 20140371194
    Abstract: This invention relates generally to the discovery of a method of inhibiting, preventing or treating bacterial infections. The invention also relates to a method of inhibiting bacterial capsule biogenesis.
    Type: Application
    Filed: June 16, 2014
    Publication date: December 18, 2014
    Inventors: Patrick C. Seed, Carlos C. Goller, Apurba Dutta, Brooks Maki, Frank Schoenen, James Noah, Lucile White
  • Publication number: 20100322936
    Abstract: The invention provides LM-1 antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions. The invention also provides antibodies, functional fragments, modified and variant forms that bind to LM-1 antigen (e.g., NONO/nmt55). Antibodies, functional fragments, modified and variant forms, nucleic acid and other compositions are useful in treatment and diagnostic methods. One method includes treating metastasis of a neoplasia, tumor or cancer in a subject in need of treatment by administering to the subject an amount of a LM-1 antibody, an antibody that binds to LM-1 antigen, or a functional fragment thereof, effective to treat metastasis of the neoplasia, tumor or cancer in the subject.
    Type: Application
    Filed: June 15, 2009
    Publication date: December 23, 2010
    Applicant: PATRYS LIMITED
    Inventors: HEINZ PETER VOLLMERS, STEPHANIE UTE BRANDLEIN, ANDREAS THALHEIMER, LEODEVICO L. ILAG, BARBARA E. POWER, LISHANTHI UDABAGE, FRANK HENSEL, FRANK SCHOENEN, ARNDT-RENE KELTER, CHRISTOPHER GARTH HOSKING